EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Contribution of epidermal growth factor (EGF) in the treatment of cutaneous leishmaniasis caused by Leishmania major in BALB/c mice

Mohammad Saberi, Alireza Latifi, Majid Golkar, Pezhman Fard-Esfahani, Sina Mohtasebi, Aref Teimouri, Mohammad Javad Abbaszadeh Afshar, Elham Kazemirad, Mehdi Mohebali iD

PLOS Neglected Tropical Diseases · 2025

DOI: 10.1371/journal.pntd.0012765 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Neglected Tropical Diseases, 2025. Verfasst von Mohammad Saberi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Parasitology and Mycology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran. Hauptthemen laut MEDLINE: Leishmaniasis, Cutaneous, Epidermal Growth Factor, Leishmania major, Antiprotozoal Agents. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Tehran University of Medical Sciences and Health Services.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cutaneous leishmaniasis (CL) is a tropical disease that can cause chronic lesions and leave life-long scars, leading to social stigmatization and psychological disorders. Using growth factors and immunomodulatory agents that could accelerate wound healing and reduce the scar is highly demanded. Epidermal growth factor (EGF) plays an essential role in wound healing. It stimulates the proliferation of keratocytes and fibroblasts, and promotes re-epithelialization. Here, the effect of EGF in combination with Glucantime and nano-liposomal Amphotericin B (SinaAmpholeish) on the healing process of CL in BALB/c mice was investigated. Seventy-two mice were infected with Leishmania major parasites and randomly divided into eight treatment groups after the appearance of the lesion. The treatment was continued for five weeks, and lesion sizes were measured weekly. Parasite load was determined in the skin biopsies using qPCR. We found that subcutaneous injection of EGF at 4.5 μg/kg, combined with each of the two antileishmanial drugs, significantly reduced the wound size and parasite load; however, EGF at 1.5 μg/kg failed to be effective. Besides, the wound size and parasite loads were significantly lower in the SinaAmfoleish groups compared to the Glucantime groups. Among the treatment groups, EGF 4.5 μg/kg combined with SinaAmpholeish exhibited the most significant reduction in wound size and parasitic load. Our results suggest that EGF can potentiate the wound healing effect of antileishmanial drugs. Further studies are warranted to explore the beneficial effects of combining EGF with antileishmanial drugs in patients with cutaneous leishmaniasis in order to accelerate wound healing and reduce the scar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Leishmaniasis, CutaneousEpidermal Growth FactorLeishmania majorAntiprotozoal AgentsAnimalsMice, Inbred BALB CMiceWound HealingParasite LoadFemaleAmphotericin BMeglumine AntimoniateDisease Models, AnimalSkinDrug Therapy, Combination

Substanzen

Epidermal Growth FactorAntiprotozoal AgentsAmphotericin BMeglumine Antimoniateliposomal amphotericin B

Autor:innen und Institutionen

  • Department of Medical Parasitology and Mycology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
  • Department of Parasitology, Pasteur Institute of Iran, Tehran, Iran.
  • Department of Biochemistry, Pasteur Institute of Iran, Tehran, Iran.
  • Department of Parasitology and Mycology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
  • Department of Parasitology and Mycology, School of Medicine, Jiroft University of Medical Sciences, Jiroft, Iran.
  • Center for Research of Endemic Parasites of Iran, Tehran University of Medical Sciences, Tehran, Iran.

ORCID-Profile: Mehdi Mohebali

Förderung

  • Tehran University of Medical Sciences and Health Services

Zitieren

APA

Saberi, M., Latifi, A., Golkar, M., Fard-Esfahani, P., Mohtasebi, S., Teimouri, A., Abbaszadeh Afshar, M. J., Kazemirad, E., & Mohebali, M. (2025). Contribution of epidermal growth factor (EGF) in the treatment of cutaneous leishmaniasis caused by Leishmania major in BALB/c mice. PLOS Neglected Tropical Diseases. https://doi.org/10.1371/journal.pntd.0012765

Vancouver

Saberi M, Latifi A, Golkar M, Fard-Esfahani P, Mohtasebi S, Teimouri A, et al. Contribution of epidermal growth factor (EGF) in the treatment of cutaneous leishmaniasis caused by Leishmania major in BALB/c mice. PLOS Neglected Tropical Diseases. 2025. doi:10.1371/journal.pntd.0012765

BibTeX
@article{Saberi2025,
  author = {Saberi, Mohammad and Latifi, Alireza and Golkar, Majid and Fard-Esfahani, Pezhman and Mohtasebi, Sina and Teimouri, Aref and Abbaszadeh Afshar, Mohammad Javad and Kazemirad, Elham and Mohebali, Mehdi},
  title = {Contribution of epidermal growth factor (EGF) in the treatment of cutaneous leishmaniasis caused by Leishmania major in BALB/c mice},
  journal = {PLOS Neglected Tropical Diseases},
  year = {2025},
  doi = {10.1371/journal.pntd.0012765}
}
Kostenlos starten →